- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06248398
Impact of Robotic Cochlear Implantation on Hearing Performance in Noise (ROBOT-IC-BRUIT)
The purpose of this study is to compare two methods of cochlear implantation : conventional manual insertion versus robot-assisted in order to verify whether robotic insertion provides better performance in the noisy environment.
To do this, we will compare the two methods of insertion of the electrode holder, on 140 patients candidates for cochlear implantation randomized in two groups (70 conventional surgery versus 70 robot-assisted surgery). All patients will be recruited during 17 months, in our Ear, nose and throat (ENT) Department of the Pitié-Salpêtrière hospital group, the first center for adult patients established in France (on average 180 patients/year).
Patient will be followed for 9 months with clinical evaluation, imaging, audiometric, listening effort and quality of life assessments. These evaluations will be carried out preoperatively and postoperatively at 3 months and 6 months post-activation of the cochlear implant.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
In the case of severe (70 to 90dB loss) and profound (>90dB loss) hearing loss, when conventional hearing aids no longer provide sufficient benefit, cochlear implantation remains the only possible solution for hearing rehabilitation. In implanted patients, a clear improvement in communication in silence is observed, but almost all patients have difficulty understanding speech in noisy environments. Cochlear implantation involves inserting an electrode holder into the cochlea during a surgical procedure under general anesthesia. The insertion of the electrode holder must be as minimally traumatic as possible in order to preserve the cochlear structures and avoid post-operative fibrosis that could impact the auditory outcomes.
The conventional method of this surgery is the manual insertion of the electrode holder. In recent years, robotic assistance, the RobOtol®, has been developed with the aim of avoiding the jerks of the surgeon's hand and improving the precision of the insertion. RobOtol® has had its CE marking since 2016 and is used in several hospitals in France and abroad.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Ghizlene LAHLOU, Dr
- Phone Number: 01 42 16 26 10
- Email: ghizlene.lahlou@aphp.fr
Study Contact Backup
- Name: Isabelle MOSNIER, Dr
- Phone Number: 01 42 16 26 10
- Email: isabelle.mosnier@aphp.fr
Study Locations
-
-
-
Paris, France, 75013
- Recruiting
- Groupe Hospitalier Pitie-Salpetriere
-
Contact:
- Ghizlene LAHLOU, Dr
- Phone Number: 01 42 16 31 67
- Email: ghizlene.lahlou@aphp.fr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adult patient ≥ 18 years old
- Patients with an indication for uni or bilateral, simultaneous or sequential cochlear implantation: severe to profound bilateral deafness with intelligibility ≤70% for Fournier dissyllabic words, in free field, at 60dB with adapted hearing aids.
- Patient able to understand the information note and give written consent
- Affiliation to a French social security system
Exclusion Criteria:
- Patient who does not speak French
- Etiologies of deafness known to be of bad prognosis (auditory neuropathy, congenital profound deafness, immediate post-meningitis profound deafness, vestibular schwannoma on the side of the ear to be implanted)
- Impossibility of testing the effect of the cochlear implant alone on hearing results (cochlear implantation in the context of unilateral deafness or fluctuating deafness)
- Cochlear implantation requiring the use of a perimodiolar electrode holder.
- Pregnant and breastfeeding women
- Patients wearing electronic devices, in direct connection with the brain or nervous system
- Patient included in another interventional study (Jardé 1)
- Patient under legal protection (guardianship or curatorship) or deprived of liberty
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experimental arm
Patient having cochlear implantation surgery with RobOtol®.
|
Patient having cochlear implantation surgery with RobOtol®.
|
|
Other: Control arm
Patient having conventional manual cochlear implantation surgery.
|
Patient having conventional manual cochlear implantation surgery
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Auditory performance in noise with the cochlear implant
Time Frame: At 6 months post-implantation
|
Evolution of the intelligibility score (Variation of the percentage of words understood) for monosyllabic Lafon words presented at 60 dB SPL with a signal-to-noise ratio of 10 dB (SNR10) between the preoperative score and the score at 6 months post-implantation
|
At 6 months post-implantation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hearing performance in noise after robotic cochlear implantation compared to conventional manual cochlear implantation for phonemes
Time Frame: At 3 and 6 months post-implantation
|
Evolution of the intelligibility score (Variation of the percentage of words and phonemes understood) for monosyllabic Lafon words presented at 60 dB SPL with a signal-to-noise ratio of 10 dB (SNR10) between the preoperative score and the score at 3 months and at 6 months post-implantation.
|
At 3 and 6 months post-implantation
|
|
Hearing performance in noise under ecological conditions after robotic cochlear implantation compared to conventional manual cochlear implantation
Time Frame: At 3 and 6 months post-implantation
|
Evolution of the intelligibility score (Variation of the percentage of words understood) for Fr-Bio words presented at 60 dB SPL with a signal-to-noise ratio of 10 dB (SNR10) between the preoperative score and the score at 3 months and at 6 months post-implantation.
The noise will be an ecological noise (restaurant or street noise) using the Immersion® system.
|
At 3 and 6 months post-implantation
|
|
Hearing performance in silence after robotic cochlear implantation compared to conventional manual cochlear implantation for words
Time Frame: At 3 and 6 months post-implantation
|
Evolution of the intelligibility score (Variation of the percentage of words understood) for monosyllabic Lafon words presented at 60 dB SPL in quiet between the preoperative score and the score at 3 months and at 6 months post-implantation.
|
At 3 and 6 months post-implantation
|
|
Hearing performance in silence after robotic cochlear implantation compared to conventional manual cochlear implantation for phonemes
Time Frame: At 3 and 6 months post-implantation
|
Evolution of the intelligibility score (Variation of the percentage of phonemes understood) for monosyllabic Lafon words presented at 60 dB SPL in quiet between the preoperative score and the score at 3 months and at 6 months post-implantation.
|
At 3 and 6 months post-implantation
|
|
The subjective benefit on tinnitus after robotic cochlear implantation compared to conventional manual cochlear implantation
Time Frame: At 3 and 6 months post-implantation
|
Evolution of the Patient's Related Outcomes Measures using questionnaire concerning the tinnitus with the Tinnitus Handicap Inventory (THI)
|
At 3 and 6 months post-implantation
|
|
The subjective benefit on quality of life after robotic cochlear implantation compared to conventional manual cochlear implantation
Time Frame: At 3 and 6 months post-implantation
|
Evolution of the Patient's Related Outcomes Measures using the questionnaire concerning the quality of life with the Cochlear Implant Quality of Life (CIQOL)
|
At 3 and 6 months post-implantation
|
|
The position of the electrode array in the cochlea during manual and robotic insertions
Time Frame: At day one post -implantation
|
the position of each electrode will be analyzed blindly on the post-operative CT-scan.
|
At day one post -implantation
|
|
The impact of a translocation on auditory performance in silence and in noise
Time Frame: At 3 and 6 months post-implantation
|
Auditory scores measured at 3 and 6 months after implantation will be correlated to the presence of a translocation of the electrode array assessed on the post-operative CT scan.
|
At 3 and 6 months post-implantation
|
|
The effort of listening in silence and in noise after manual and robotic insertions assessed with the Speech, Spatial and Qualities of Hearing Scale (SSQ)
Time Frame: At 3 and 6 months post-implantation
|
The effort of listening will be analyzed with SSQ scale
|
At 3 and 6 months post-implantation
|
|
The effort of listening in silence and in noise after manual and robotic insertions assessed with a visual analog scale
Time Frame: At 3 and 6 months post-implantation
|
The effort of listening will be analyzed after each audiologic test with a visual analog scale, using which the patient will rate from 0 to 10 the effort made to understand the words presented (Bräcker et al., 2019)
|
At 3 and 6 months post-implantation
|
|
The preservation of residual hearing after cochlear implantation in cases with residual hearing before surgery
Time Frame: At 30 days, 3 months and 6 months post-implantation
|
Evolution of auditory thresholds measured with tonal audiometry between preoperative and postoperative measurements on the operated ear.
|
At 30 days, 3 months and 6 months post-implantation
|
|
The presence of postoperative vertigo in case of robotic cochlear implantation compared to manual implantation
Time Frame: At 7 days, 3 months and 6 months post-implantation
|
Evaluation of vertigo with the Dizziness Handicap Inventory (DHI) questionnaire
|
At 7 days, 3 months and 6 months post-implantation
|
Collaborators and Investigators
Investigators
- Principal Investigator: Ghizlene LAHLOU, Dr, Assistance Publique - Hôpitaux de Paris
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- APHP211330
- 2023-A00837-38 (Other Identifier: N°IDRCB)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Severe to Profound Hearing Loss
-
Assistance Publique - Hôpitaux de ParisCochlearNot yet recruitingSevere to Profound Sensorineural Hearing Loss
-
Novartis PharmaceuticalsCompletedUnilateral Severe to Profound Hearing Loss OR Bilateral Severe to Profound Hearing LossUnited States
-
CochlearCompletedSevere to Profound Mixed Hearing LossGermany
-
Advanced Bionics AGCompletedSevere-to-profound Hearing LossNetherlands
-
Imam Abdulrahman Bin Faisal UniversityCompletedSevere to Profound Sensorineural Hearing Loss | Undergoing Cochlear Implant SurgerySaudi Arabia
-
Advanced Bionics AGRecruitingHearing Loss, Sensorineural | Severe-to-profound Hearing LossUnited Kingdom, Poland, Italy, Spain, Belgium, France, Germany
-
Assistance Publique - Hôpitaux de ParisURC-CIC Paris Descartes Necker CochinRecruitingSevere to Profound Prelingual Hearing LossFrance
-
Advanced BionicsCompletedSevere to Profound Hearing Loss | in Adult Users of Advanced Bionics HiResolution™ Bionic Ear SystemUnited States
-
Cambridge University Hospitals NHS Foundation TrustAdvanced Bionics AGCompletedHearing Loss, Bilateral | Cochlear Implant | Hearing Loss, Cochlear | Severe-Profound Hearing LossUnited Kingdom
-
Oticon MedicalNot yet recruitingSensorineural Hearing Loss, Bilateral | Sensorineural Hearing Loss, Severe | Sensorineural Hearing Loss, Profound
Clinical Trials on Surgery with RobOtol®
-
FX SolutionsRecruitingShoulder Fractures | Shoulder Disease | Shoulder Arthroplasty for Revision of Previous TreatmentMonaco, France
-
Minneapolis Veterans Affairs Medical CenterDepuy, Inc.TerminatedOsteoarthritis, KneeUnited States
-
Shashi DadlaniNot yet recruitingPeriodontal Bone Loss | Periodontal Defect | Periodontitis Stage III | Periodontitis Stage IV
-
Poitiers University HospitalCompleted
-
Sixth Affiliated Hospital, Sun Yat-sen UniversityNanfang Hospital of Southern Medical UniversityNot yet recruiting
-
University of ValenciaCompletedDental Implant | Computer-assistedSpain
-
Medical University of GrazRecruiting
-
SC MedicaRecruitingDegenerative Lumbar Spinal StenosisFrance
-
University Hospital, CaenUnknownQuality of Life | Pain, Postoperative | Complication | RelapseFrance
-
Second Affiliated Hospital, School of Medicine,...Recruiting